Phase 2 Study of Oral AB1010 in Non Pre-treated, Inoperable Patients With Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Objective response rate according to Response Evaluation Criteria In Solid Tumors (RECIST)
2 months
No
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
AB04016
NCT00998751
June 2005
June 2014
Name | Location |
---|